edrophonium has been researched along with Kidney Failure, Chronic in 2 studies
Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " When present, the physician may want to determine whether the patient has myasthenia gravis--the commonest of all neuromuscular disorders--and administer the edrophonium (Tensilon) test." | 3.69 | Interpretation of positive edrophonium (Tensilon) test in patients with end-stage renal disease. ( Bank, N; Khan, GA, 1995) |
| "Seventeen patients with end stage chronic renal failure and 18 patients with normal renal function were anaesthetized with 0." | 2.67 | Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function. ( Cashman, JN; Jones, RM; Luke, JJ, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, GA | 1 |
| Bank, N | 1 |
| Cashman, JN | 1 |
| Luke, JJ | 1 |
| Jones, RM | 1 |
1 trial available for edrophonium and Kidney Failure, Chronic
| Article | Year |
|---|---|
Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
Topics: Adult; Aged; Anesthesia, General; Drug Evaluation; Edrophonium; Female; Hemodynamics; Humans; Isoqui | 1990 |
1 other study available for edrophonium and Kidney Failure, Chronic
| Article | Year |
|---|---|
Interpretation of positive edrophonium (Tensilon) test in patients with end-stage renal disease.
Topics: Aged; Chronic Disease; Diabetic Nephropathies; Edrophonium; False Positive Reactions; Female; Humans | 1995 |